BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/29/2021 8:06:15 AM | Browse: 82 | Download: 230
Publication Name World Journal of Gastroenterology
Manuscript ID 62330
Country China
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
Manuscript Source Unsolicited Manuscript
All Author List Yin-Lian Wu, Rahul Kumar, Ming-Fang Wang, Medha Singh, Jiao-Feng Huang, Yue-Yong Zhu and Su Lin
Funding Agency and Grant Number
Funding Agency Grant Number
Chinese National 13th Five-Year Plan's Science and Technology Projects 2017ZX10202201
Corresponding Author Su Lin, MD, PhD, Associate Chief Physician, Professor, Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou 350005, Fujian Province, China. sumer5129@fjmu.edu.cn
Key Words Metabolic associated fatty liver disease; Non-invasive fibrosis scores; Fibrosis-4 index; Non-alcoholic fatty liver disease fibrosis score; Aspartate aminotransferase to platelet ratio index; BARD
Core Tip Metabolic associated fatty liver disease (MAFLD) is a new concept proposed in 2020 to re-define fatty liver disease. The utility of non-invasive fibrosis scores as well as their optimal thresholds for MAFLD remains unknown. We validated the conventional non-invasive scores including aspartate aminotransferase to platelet ratio index, fibrosis-4 index, diabetes score (BARD), and non-alcoholic fatty liver disease fibrosis score in patients with MAFLD. The results indicate that the conventional scores may lead to a high rate of misdiagnosis in MAFLD. Novel scoring system for fibrosis is urgently needed.
Citation Wu YL, Kumar R, Wang MF, Singh M, Huang JF, Zhu YY, Lin S. Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease. World J Gastroenterol 2021; 27(34): 5753-5763
Received
2021-01-06 13:44
Peer-Review Started
2021-01-06 13:45
To Make the First Decision
Return for Revision
2021-05-05 22:18
Revised
2021-05-15 09:29
Second Decision
2021-07-29 02:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-07-29 08:06
Articles in Press
2021-07-29 08:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-08-17 21:14
Typeset the Manuscript
2021-09-02 03:46
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com